严重发热伴血小板减少综合征
医学
病死率
流行病学
内科学
肌痛
血清流行率
淋巴细胞减少症
儿科
免疫学
血清学
抗体
病毒
淋巴细胞
作者
Chen-Tao Guo,Qimei Lu,Shujun Ding,Cheng‐Yang Hu,Jing Hu,Ying Wo,Ya-Di Fan,X.-J. Wang,Shu-Li Qin,Ning Cui,Ziyue Yang,X.-A. Zhang,Wei Liu,Wu-Chun Cao
标识
DOI:10.1017/s0950268815002678
摘要
SUMMARY Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease that was caused by a novel bunyavirus, SFTSV. The study aimed to disclose the epidemiological and clinical characteristics of SFTSV infection in China so far. An integrated clinical database comprising 1920 SFTS patients was constructed by combining first-hand clinical information collected from SFTS sentinel hospitals ( n = 1159) and extracted data ( n = 761) from published literature. The considered variables comprised clinical manifestations, routine laboratory tests of acute infection, hospitalization duration and disease outcome. SFTSV-IgG data from 19 119 healthy subjects were extracted from the published papers. The key clinical variables, case-fatality rate (CFR) and seroprevalence were estimated by meta-analysis. The most commonly seen clinical manifestations of SFTSV infection were fever, anorexia, myalgia, chill and lymphadenopathy. The major laboratory findings were elevated lactate dehydrogenase, aminotransferase, followed by thrombocytopenia, lymphocytopenia, elevated alanine transaminase and creatine kinase. A CFR of 12·2% was estimated, significantly higher than that obtained from national reporting data, but showing no geographical difference. In our paper, the mortality rate was about 1·9 parts per million. Older age and longer delay to hospitalization were significantly associated with fatal outcome. A pooled seroprevalence of 3·0% was obtained, which increased with age, while comparable for gender. This study represents a clinical characterization on the largest group of SFTS patients up to now. A higher than expected CFR was obtained. A wider spectrum of clinical index was suggested to be used to identify SFTSV infection, while the useful predictor for fatal outcome was found to be restricted.
科研通智能强力驱动
Strongly Powered by AbleSci AI